State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
Institute of Biomedical Sciences, Fudan University, Shanghai, China.
Life Sci. 2024 Jun 15;347:122605. doi: 10.1016/j.lfs.2024.122605. Epub 2024 Apr 18.
Hepatocellular carcinoma (HCC) is a lead cause of cancer-related deaths. In the present study we investigated the role of Brahma-related gene 1 (BRG1), a chromatin remodeling protein, in HCC the pathogenesis focusing on identifying novel transcription targets.
Hepatocellular carcinogenesis was modeled in mice by diethylnitrosamine (DEN). Cellular transcriptome was evaluated by RNA-seq.
Hepatocellular carcinoma was appreciably retarded in BRG1 knockout mice compared to wild type littermates. Transcriptomic analysis identified ATP Binding Cassette Subfamily C Member 3 (ABCC3) as a novel target of BRG1. BRG1 over-expression in BRG1 HCC cells (HEP1) up-regulated whereas BRG1 depletion in BRG1 HCC cells (SNU387) down-regulated ABCC3 expression. Importantly, BRG1 was detected to directly bind to the ABCC3 promoter to activate ABCC3 transcription. BRG1 over-expression in HEP1 cells promoted proliferation and migration, both of which were abrogated by ABCC3 silencing. On the contrary, BRG1 depletion in SNU387 cells decelerated proliferation and migration, both of which were rescued by ABCC3 over-expression. Importantly, high BRG1/ABCC3 expression predicted poor prognosis in HCC patients. Mechanistically, ABCC3 regulated hepatocellular carcinogenesis possibly by influencing lysosomal homeostasis.
In conclusion, our data suggest that targeting BRG1 and its downstream target ABCC3 can be considered as a reasonable approach for the intervention of hepatocellular carcinoma.
肝细胞癌(HCC)是癌症相关死亡的主要原因。本研究我们研究了染色质重塑蛋白Brahma 相关基因 1(BRG1)在 HCC 发病机制中的作用,重点是确定新的转录靶标。
通过二乙基亚硝胺(DEN)在小鼠中建立肝细胞癌模型。通过 RNA-seq 评估细胞转录组。
与野生型同窝仔相比,BRG1 基因敲除小鼠的肝细胞癌明显延迟。转录组分析确定 ATP 结合盒亚家族 C 成员 3(ABCC3)为 BRG1 的新靶标。BRG1 在 BRG1 HCC 细胞(HEP1)中的过表达上调,而 BRG1 在 BRG1 HCC 细胞(SNU387)中的耗竭下调 ABCC3 表达。重要的是,BRG1 被检测到直接结合 ABCC3 启动子以激活 ABCC3 转录。BRG1 在 HEP1 细胞中的过表达促进增殖和迁移,而 ABCC3 的沉默则消除了这两种作用。相反,BRG1 在 SNU387 细胞中的耗竭减缓了增殖和迁移,而 ABCC3 的过表达则挽救了这两种作用。重要的是,高 BRG1/ABCC3 表达预示着 HCC 患者的预后不良。从机制上讲,ABCC3 可能通过影响溶酶体稳态来调节肝细胞癌的发生。
综上所述,我们的数据表明,靶向 BRG1 及其下游靶标 ABCC3 可以被认为是干预肝细胞癌的一种合理方法。